about
Role of microglia in central nervous system infectionsThe positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disordersImaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologiesTranslocator protein 18 kDa (TSPO): molecular sensor of brain injury and repairBiomarkers of Alzheimer's diseaseChronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptorsMaximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's diseaseAmyloidosis in Retinal Neurodegenerative DiseasesTargeting innate immunity for neurodegenerative disorders of the central nervous systemInsight into the Molecular Imaging of Alzheimer's DiseaseDocosahexaenoic Acid and Cognition throughout the LifespanThe methodology of TSPO imaging with positron emission tomographyFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesPotential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's DiseaseMicroglial cell dysregulation in brain aging and neurodegenerationBioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connectionHow do immune cells support and shape the brain in health, disease, and aging?The role of inflammasome in Alzheimer's diseaseAmyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's diseaseGap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseasesNeuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapyGlial cells in (patho)physiologyBlood markers of oxidative stress in Alzheimer's diseaseRole of microglia in CNS inflammationThe development, past achievements, and future directions of brain PETMicroglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative diseaseChronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) miceCheckpoints to the Brain: Directing Myeloid Cell Migration to the Central Nervous SystemImaging neuroinflammation in multiple sclerosis using TSPO-PETmiR-155 is involved in Alzheimer's disease by regulating T lymphocyte functionPeripheral benzodiazepine receptors: on mice and human brain imagingIn vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's diseaseMolecular mechanisms of cognitive dysfunction following traumatic brain injuryMaintaining brain health by monitoring inflammatory processes: a mechanism to promote successful agingBrain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s diseasePositron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brainIn vivo dynamics of innate immune sentinels in the CNS.MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's diseaseThe role of astrocytes in CNS tumors: pre-clinical models and novel imaging approaches
P2860
Q24563024-A1AD2EDD-15E3-4C63-9E77-44B31DF144C1Q24641816-8CE31B00-182D-4C89-B7D6-E131FD3385C5Q24642726-08BCF1A3-2A42-44F1-97B0-6C920B180107Q24644752-F5FA3F9A-2B50-4544-A200-A3589D21C85AQ24650667-574F990B-FB7E-4F38-9EB0-07C846B82035Q24796326-391170A9-6CC7-4240-B38F-6B7986DEEAA3Q24815590-A10FF616-9A45-42AC-AF63-367C7B9DAA67Q26739839-AC9BF954-565D-4C9D-BF32-D1522B46FB8CQ26744219-671E7ADF-BF42-4DEA-9096-B267811F6FD0Q26765945-D141CCB7-36B9-42CE-A403-8EA32FE0A973Q26768442-72E9C897-DBEE-40D3-82B7-C245D7F144F6Q26778370-FD5E9D8D-3B73-495E-B5A7-FDD82A586ACFQ26779933-4CBEE34E-4179-419A-A612-E0176E8F4158Q26783325-84967360-51AD-4BF7-8FA1-FB15CD0E12CEQ26800212-FC08F1A6-CCB7-4116-8954-87D6DA01B5AAQ26822410-FF274725-1743-420C-B271-BAFA3F001472Q26995364-81A04CEC-3643-4962-A794-077CC039E246Q26996822-01461779-EC01-423A-B929-69148D50846AQ27009411-2ABF9396-BB38-4150-9D7F-65F877A64478Q27012316-211A0917-9F16-49FD-8F12-51D01202C1A3Q27014919-416889DD-D4E0-48A6-B13E-152F898C1E4BQ27021135-0CE15E47-E8F3-4A5E-A783-C7BEA11738A6Q27021625-719CE5AA-4E18-4DC7-9B3F-5A5A3A211611Q27023760-4D67CEFB-E72C-4FEF-B28C-D8C08D60464AQ27026331-834062A6-B4A8-45B6-BD55-B511607B5423Q27026599-F08C0DF9-1ADF-4438-94B4-BBC9FCFC11F7Q27339727-49FB471E-A6B2-432E-AC53-B7D4AD090151Q28066906-9D6D8255-78F7-43FA-9088-62FAFD418C89Q28084625-913F8FF3-E197-44C9-B15E-0AEDD247D8C0Q28087564-EED7FA42-4CF7-4AF1-92CE-1FA8321F61BEQ28206161-00178C27-818F-4CF2-AC53-AA3EF66FE6DDQ28274003-435DE454-6FA4-4B2B-B666-AA8FBA56DED0Q28385324-BF71B24B-83C1-4509-B457-0F2338DECF06Q28730725-15F9AE7B-6B3D-472A-8A4C-DE3633E7E942Q30141537-6D4611C8-7FE6-4D68-8A81-CBF94799B2CFQ30497749-7AE26607-DDF0-49B9-BF86-1ED381F34EDFQ30542245-F64F1EFA-DBD2-4770-B7D4-FFC1B6073482Q30547038-3E3FA414-AF52-42EA-94BC-CFD5D1943A9AQ30572242-E351FFB2-C4B1-4E2D-99F8-6EBABDE0C10BQ30618244-AA2613A1-5D6B-4305-9335-11E3C72D9112
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
In-vivo measurement of activated microglia in dementia.
@en
In-vivo measurement of activated microglia in dementia.
@nl
type
label
In-vivo measurement of activated microglia in dementia.
@en
In-vivo measurement of activated microglia in dementia.
@nl
prefLabel
In-vivo measurement of activated microglia in dementia.
@en
In-vivo measurement of activated microglia in dementia.
@nl
P2093
P50
P1433
P1476
In-vivo measurement of activated microglia in dementia.
@en
P2093
P304
P356
10.1016/S0140-6736(01)05625-2
P407
P577
2001-08-01T00:00:00Z